PASO vs LLY: Which Stock is Better?
Side-by-side comparison of Patient Access Solutions Inc and Eli Lilly & Co in 2026
PASO
Patient Access Solutions Inc
$0.00
LLY
Eli Lilly & Co
$927.03
Key Metrics Comparison
| Metric | PASO | LLY | Winner |
|---|---|---|---|
| Market Cap | $0.25M | $829.71B | LLY |
| P/E Ratio | N/A | 40.38 | LLY |
| EPS (TTM) | $N/A | $22.96 | LLY |
| Revenue Growth | -0.0% | 0.4% | LLY |
| Gross Margin | 98.2% | 83.0% | PASO |
Analyze PASO
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PASO or LLY a better investment?
Comparing PASO and LLY: Patient Access Solutions Inc has a market cap of $0.25M while Eli Lilly & Co has $829.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PASO and LLY?
PASO (Patient Access Solutions Inc) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PASO or LLY?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PASO or LLY?
LLY has higher revenue growth at 0.4% vs -0.0% for PASO.
Which company is more profitable: PASO or LLY?
Patient Access Solutions Inc (PASO) has higher gross margins at 98.2% compared to 83.0% for LLY.
Which is the larger company: PASO or LLY?
Eli Lilly & Co (LLY) is larger with a market cap of $829.71B compared to $0.25M for PASO.
Should I buy PASO or LLY in 2026?
Both PASO and LLY have investment merit. PASO trades at $0.00 while LLY trades at $927.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PASO and LLY stock?
Key differences: Market Cap ($0.25M vs $829.71B), P/E Ratio (N/A vs 40.4x), Revenue Growth (-0.0% vs 0.4%), Gross Margin (98.2% vs 83.0%).